| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 237.082.221 $ | +7.371.341 $ | -1,8 % | 8 | 229.710.880 $ | +47.102.415 $ | +41,6 % | 7 | 182.608.465 $ | +63.525.466 $ | +33,7 % | 6 | ||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 134.994.913 $ | +2.389.290 $ | +1,8 % | 1 | 132.605.623 $ | +13.380.027 $ | +11,2 % | 1 | 119.225.596 $ | +41.599.370 $ | +53,6 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 33.172.173 $ | +4.052.109 $ | +13,9 % | 1 | 29.120.064 $ | +3.932.171 $ | +15,6 % | 1 | 25.187.893 $ | +25.187.893 $ | 1 | |
| Lyell Immunopharma, Inc. | LYEL | → 0 | Neutral | 16.056.004 $ | -8.580.277 $ | -34,8 % | 1 | 24.636.281 $ | +11.637.801 $ | +89,5 % | 1 | 12.998.480 $ | +5.922.953 $ | +83,7 % | 1 |
| Maze Therapeutics, Inc. | MAZE | → 0 | Sehr schwach | 4.683.495 $ | -16.970.185 $ | -78,4 % | 1 | 21.653.680 $ | +8.101.184 $ | +59,8 % | 1 | 13.552.496 $ | -12.360.750 $ | -47,7 % | 1 |
| Eikon Therapeutics, Inc. | EIKN | → 0 | Schwach | 20.564.156 $ | +20.564.156 $ | 1 | |||||||||
| Relay Therapeutics, Inc. | RLAY | → 0 | Schwach | 9.950.000 $ | +1.490.000 $ | +17,6 % | 1 | 8.460.000 $ | +3.240.000 $ | +62,1 % | 1 | 5.220.000 $ | +1.760.000 $ | +50,9 % | 1 |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 9.304.000 $ | +2.132.800 $ | +29,7 % | 1 | 7.171.200 $ | +747.200 $ | +11,6 % | 1 | 6.424.000 $ | +1.416.000 $ | +28,3 % | 1 |
| Alector, Inc. | ALEC | → 0 | Neutral | 8.357.480 $ | +2.293.448 $ | +37,8 % | 1 | 6.064.032 $ | +6.064.032 $ | 1 | |||||
| 237.082.221 $ | +7.371.341 $ | -1,8 % | 8 | 229.710.880 $ | +47.102.415 $ | +41,6 % | 7 | 182.608.465 $ | +63.525.466 $ | +33,7 % | 6 | ||||